Literature DB >> 19513667

Functional analysis of mutant mitochondrial DNA polymerase proteins involved in human disease.

Sherine S L Chan1, William C Copeland.   

Abstract

DNA polymerase gamma (pol gamma) is the only DNA polymerase within the mitochondrion and is thus essential for replication and repair of mtDNA. POLG, the gene encoding the catalytic subunit of pol gamma, is a major locus for a wide spectrum of mitochondrial diseases with more than 100 known disease mutations. Thus, we need to understand how and why pol gamma defects lead to disease. By using an extensive array of methods, we are developing a clearer understanding of how defects in pol gamma contribute to disease. Furthermore, crucial knowledge concerning the role of pol gamma in mtDNA replication and repair can be acquired. Here we present the protocols to characterize mutant DNA pol gamma proteins, namely, assays for processive DNA synthesis, exonuclease activity, DNA binding, subunit interaction, and protein stability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513667      PMCID: PMC2886993          DOI: 10.1007/978-1-59745-521-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Solution structure of the lyase domain of human DNA polymerase lambda.

Authors:  Eugene F DeRose; Thomas W Kirby; Geoffrey A Mueller; Katarzyna Bebenek; Miguel Garcia-Diaz; Luis Blanco; Thomas A Kunkel; Robert E London
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

Review 2.  Mitochondrial DNA and disease.

Authors:  Salvatore Dimauro; Guido Davidzon
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

Review 3.  DNA polymerase gamma in mitochondrial DNA replication and repair.

Authors:  Maria A Graziewicz; Matthew J Longley; William C Copeland
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

4.  Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity.

Authors:  M J Longley; P A Ropp; S E Lim; W C Copeland
Journal:  Biochemistry       Date:  1998-07-21       Impact factor: 3.162

5.  Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia.

Authors:  Matthew J Longley; Susanna Clark; Cynthia Yu Wai Man; Gavin Hudson; Steve E Durham; Robert W Taylor; Simon Nightingale; Douglass M Turnbull; William C Copeland; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2006-05-04       Impact factor: 11.025

6.  Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.

Authors:  S E Lim; W C Copeland
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

7.  Developing a systematic approach to the diagnosis and classification of mitochondrial disease.

Authors:  Robert K Naviaux
Journal:  Mitochondrion       Date:  2004-09       Impact factor: 4.160

8.  Functional human mitochondrial DNA polymerase gamma forms a heterotrimer.

Authors:  Elena Yakubovskaya; Zhixin Chen; José A Carrodeguas; Caroline Kisker; Daniel F Bogenhagen
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

9.  The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit.

Authors:  Sherine S L Chan; Matthew J Longley; William C Copeland
Journal:  J Biol Chem       Date:  2005-07-16       Impact factor: 5.157

10.  Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.

Authors:  Susan E Lim; Mikhail V Ponamarev; Matthew J Longley; William C Copeland
Journal:  J Mol Biol       Date:  2003-05-23       Impact factor: 5.469

View more
  3 in total

Review 1.  Purification and functional characterization of human mitochondrial DNA polymerase gamma harboring disease mutations.

Authors:  Rajesh Kasiviswanathan; Matthew J Longley; Matthew J Young; William C Copeland
Journal:  Methods       Date:  2010-02-20       Impact factor: 3.608

2.  ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions.

Authors:  Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2010-05-26       Impact factor: 14.195

3.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.